Use of gabapentin to treat focal status epilepticus

Journal of Epilepsy

Volumn 10, Issue 6, 1997, Pages 291-293

  Ettinger, Alan B ^a   Devinsky, Orrin ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Focal status epilepticus; Gabapentin; Seizure

Indexed keywords

GABAPENTIN; LORAZEPAM; PENTOBARBITAL; PHENYTOIN;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; EPILEPTIC STATE; FOCAL EPILEPSY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031279460     PISSN: 08966974     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6974(97)00068-6     Document Type: Article

References (6)

1. 1. The U.S. Gabapentin Study Group. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drugresistant partial epilepsy. Epilepsy Res 1994;18:67-73.
2. 2. The UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990;343:1114-7.
3. 3. Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. Epilepsia 1994;35:795-801.
4. 4. Comstock TJ, Sica DA, Bockbrader HN, Underwood BA, Sedman AJ. Gabapentin pharmacokinettcs in subjects with various degrees of renal function. J Clin Pharmacol 1990;30: 862 (abstract).
5. 5. Turck D, Vollmer KO, Bockbrader H, Sedman A. Doselinearity of the new anticonvulsant gabapentin after multiple oral doses. Eur J Clin Pharmacol 1989;36 (suppl):A310 (abstract).
6. 6. Vollmer KO, Turck D, Wagner F, Jahnchen E, Anhut H, Thomann P. Multiple dose pharmacokinetics of the new anticonvulsant gabapentin. Eur J Clin Pharmacol 1989;36 (suppl):A-310 (abstract).